A Study to Evaluate the Safety, Pharmacokinetics, and Activity of XmAb24306 in Combination With Cevostamab in Participants With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT05646836 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05646836
- Sponsor
- Genentech, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2026-11-18
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.